Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Colorectal Cancer”

824 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 824 results

Not applicableUnknownNCT04710589
What this trial is testing

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

Who this might be right for
Recurrent Rectal Cancer125I Seeds ImplantationClinical Target Volume
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00025350
What this trial is testing

Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT03297710
What this trial is testing

TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Rectal AdenocarcinomaRecurrent Rectal CarcinomaStage IV Rectal Cancer AJCC v7+2 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Study completedNCT01409005
What this trial is testing

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Who this might be right for
Metastatic or Recurrent Colorectal CancerRefractory to Fluoropyrimidine, Oxaliplatin and IrinotecanSalvage Chemotherapy
Seoul National University Bundang Hospital 41
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Testing effectiveness (Phase 2)WithdrawnNCT03169777
What this trial is testing

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

Who this might be right for
Colorectal Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00002664
What this trial is testing

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
James Ahlgren
Testing effectiveness (Phase 2)Study completedNCT03427411
What this trial is testing

M7824 in Subjects With HPV Associated Malignancies

Who this might be right for
Human Papilloma VirusCervical CancerOropharyngeal Cancer+2 more
National Cancer Institute (NCI) 57
Not applicableUnknownNCT00985400
What this trial is testing

Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 154
Not applicableWithdrawnNCT07474844
What this trial is testing

Structured TXI-RDI Integration for Endoscopic Resection

Who this might be right for
Polyp ColorectalEndoscopic Mucosal Resection
Medical College of Wisconsin
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Not applicableUnknownNCT03572595
What this trial is testing

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Who this might be right for
Colo-rectal CancerRecurrence
Assiut University 45
Testing effectiveness (Phase 2)Study completedNCT00003441
What this trial is testing

Irofulven in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 26
Early research (Phase 1)Active Not RecruitingNCT06540261
What this trial is testing

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Who this might be right for
Unresectable Colorectal Cancer
Ono Pharmaceutical Co., Ltd. 65
Early research (Phase 1)Looking for participantsNCT07545122
What this trial is testing

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

Who this might be right for
Triple Negative Breast Cancer (TNBC)Colorectal CancerUrothelial Cancer
Context Therapeutics Inc. 162
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Large-scale testing (Phase 3)Study completedNCT00008060
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council
Testing effectiveness (Phase 2)Study completedNCT00748215
What this trial is testing

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerDiarrhea
M.D. Anderson Cancer Center 100
Next Page